×
Home Schedule Organizers Additional Information CORPORATE PARTNERS ZONE Contact Back to portal fr Log in
  • ☰
Sign Out

Schedule

21st ANNUAL MEETING of “FONDATION D.E.V.E.N.I.R.”

Organized in collaboration with the SQN

Day 1 program Day 2 program Corporate zone
Skills development in the CanMEDS roles targeted by this activity:
Accreditation

This activity is an accredited group learning activity (Section 1), as defined by the Royal College of Physicians and Surgeons of Canada Maintenance of Certification (MOC) Program as well as a professional development recognized activity (category A) as defined by the Collège des médecins du Québec. This activity has been approved by the Direction du Développement professionnel continu (DDPC) [Direction of Continuing Professional Development (DCPD)] of the Fédération des médecins spécialistes du Québec.

You can declare a maximum of 8.75 hours in section 1 / professional development recognized activity (category A). Participants must claim a number of hours consistent with the duration of their participation.

GENERAL OBJECTIVES
  1. To promote, through multidisciplinarity, a comprehensive healthcare approach, for clients with chronic kidney disease and for related co-morbid clinical conditions.
  2. To generate optimal use of the skills of the members of the multidisciplinary teams (physicians, pharmacists, nurses, dietitians), in the healthcare process for this client group.

    The specific objectives for each conference are found in the more details button.

***NOTE: For the 21st Colloque Annuel of ” Fondation D.E.V.E.N.I.R.“, participants will be able to register and participate in either the half-day session of continuing medical education on October 13, or that of Saturday, October 14, or the two half-day sessions of training***

SCIENTIFIC PROGRAM – DAY 1

Note: A simultaneous translation service from English to French and from French to English will be available. You must bring your headphones and your electronic devices for accessing the translation service.

Friday October 13th, 2023

11:30 - 13:00
ARRIVAL OF PARTICIPANTS (Registration) / PLENARY SESSIONS
13:00 - 13:15
OPENING REMARKS

Dr. Daniel Garceau

OVERVIEW OF SCIENTIFIC PROGRAM
13:15 - 14:25
“USAGE OF THE GASTROINTESTINAL TRACT AS A TOOL TO COUNTERACT THE HARMFUL EFFECT OF CKD: THE MISSING LINK?”

(Lecture in French)

Prof. Laetitia Koppe

“USAGE OF THE GASTROINTESTINAL TRACT AS A TOOL TO COUNTERACT THE HARMFUL EFFECT OF CKD: THE MISSING LINK?”

(Lecture in French)

Speaker

Prof. Laetitia Koppe, MD, PhD

Assistant Branch Officer
Nephrology Department
Hôpital Lyon Sud, France
Laboratoire CarMen, Inserm U1060
France

TARGETED CANMEDS SKILLS:

  • Medical Expert
  • Scholar

LEARNING OBJECTIVES:

  1. 1. To discuss the impact of CKD on the microbiome composition.
  2. 2. To explore the mechanisms underlying the impact of microbiome modification on the emergence or progression of chronic kidney disease and its cardiovascular complications.
  3. 3. To summarize the results related to modulation of the microbiome (antibiotics targeting the gastrointestinal tract, oral adsorbers binding uraemic toxins, urease) to prevent chronic kidney disease progression.
  4. 4. To propose a therapeutic plan possibly useful in the future, targeting the gastrointestinal tract to prevent chronic kidney disease progression or its cardiovascular complications, based on on-going clinical trials.

Download files

14:25 - 15:35
“SOCIAL MEDIA FOR THE NEPHROLOGISTS, SOCIAL MEDIA FOR THE PATIENTS: BLOCKBUSTERS WITH PITFALLS?”

Dr. Matthew A. Sparks

“SOCIAL MEDIA FOR THE NEPHROLOGISTS, SOCIAL MEDIA FOR THE PATIENTS: BLOCKBUSTERS WITH PITFALLS?”

Speaker

Dr. Matthew A. Sparks, MD

Associate Professor
Director Nephrology Fellowship Program
Lead, Society for Early Education Scholars (SEEDS) Program
Department of Medicine
Duke University Medical Center, Durham VA Health Care System
Durham, NC, USA

TARGETED CANMEDS SKILLS:

  • Communicator
  • Collaborator
  • Health Advocate

LEARNING OBJECTIVES:

  • 1. To discuss the emergence over the last decade of social media platforms, used either by health care professionals or CKD patients.
  • 2. To explore some of the characteristics of popular electronical tools used by nephrology community (professionals and patients, with real-life examples such as: Twitter, Facebook, discussion blogs, videos, live chats, online commentaries).
  • 3. To analyze the benefits and pitfalls of these tools to:
    • enhance education
    • share information
  • 4. To analyze the future impact of on-going usage of these tools to optimize the clinical care of CKD patients and their knowledge regarding their disease.

Download files

15:35 - 16:10 - HEALTH BREAK Corporate zone
16:10 - 18:15
“HIGHLIGHTS IN 2023 TO SHARE”

(Lectures in French)

“The Nutritionist’s Vision” - Ms. Karine Thibault, Dt.P, M.Sc., Dietician-Nutritionist

“The Nurse’s / SNP’s Vision”- Ms. Céline Irani, Inf., M.Sc, SNP Nephrology (IPSSA ) Unit

“The Nephrologist’s Vision” - Dr. Mathieu Leblanc, MD, FRCPC, Nephrologist

“The Pharmacist’s Vision” - Mr. Marc-André Thivierge, Pharm D, M. Sc., Pharmacist

Question Period

“HIGHLIGHTS IN 2023 TO SHARE”

Speakers

Ms. Karine Thibault, Dt.P, M.Sc.

Dietician-Nutritionist, Nephrology Unit
Impairment, Autism and Rehabilitation Programs Branch
Lévis, QC
Canada

Ms. Céline Irani, Inf., M.Sc

SNP in Adult Care, Nephrology (IPSSA ) Unit
CHUM
Montréal (QC)
Canada

Dr. Mathieu Leblanc, MD, FRCPC

Nephrologist
CIUSSS Saguenay-Lac-St-Jean
Hôpital de Chicoutimi
Clinical Education Professor, Faculty of Medicine, Université de Sherbrooke
Chicoutimi, QC
Canada

Mr. Marc-André Thivierge, Pharm D, M. Sc.

Pharmacist
CIUSSS de l’Estrie-CHUS, l’Hôpital de Granby
Granby, QC
Canada

TARGETED CANMEDS SKILLS:

  • Medical Expert
  • Collaborator
  • Health Avocate
  • Scholar
  • Professional

LEARNING OBJECTIVES:

To share with colleagues the vision of one member of each professional group involved, and more specifically:

  1. 1. To present relevant concepts (diagnostic, therapeutic, behavioural, organizational approaches or notions acquired in 2023) to the members of multidisciplinary teams in nephrology.
  2. 2. To illustrate how the concepts of interest acquired in 2023 can apply in a multidisciplinary practice for the different groups of healthcare professionals.
  3. 3. To integrate the concepts conveyed in the presentation to the current practice of the members of the healthcare teams.

Download files

18:45 - 19:45
COCKTAIL
19:45 - 22:00
DINNER
SCIENTIFIC PROGRAM – DAY 2

Note: Simultaneous translation from English to French and from French to English will be available. You must bring your headphones and electronic devices to benefit from the translation service.

Saturday October 14th, 2023

7:00 - 8:00
BUFFET BREAKFAST / PLENARY SESSIONS
8:00 - 8:10
OPENING REMARKS

Dr. Daniel Garceau

OVERVIEW OF SCIENTIFIC PROGRAM
8:10 - 9:20
“OUR DAY-TO-DAY MANAGEMENT OF CKD PATIENTS IN 2023; IS IT REALLY RELEVANT?”

Dr. Navdeep Tangri, MD, PhD, FRCP (C)

“OUR DAY-TO-DAY MANAGEMENT OF CKD PATIENTS IN 2023; IS IT REALLY RELEVANT?”

Speaker

Dr. Navdeep Tangri, MD, PhD, FRCP (C)
Max Rady College of Medicine
Internal Medicine
Section of Nephrology-University of Manitoba
Seven Oaks General Hospital
Winnipeg, MB
Canada

TARGETED CANMEDS SKILLS:

  • Medical Expert
  • Collaborator
  • Leader
  • Health Advocate
  • Scholar

LEARNING OBJECTIVES:

  1. 1. To briefly review the prevalence of CKD stage 3 to 5 in North America and Europe, and its causes.
  2. 2. To explore this rationale of usual imaging and lab tests ordered in the global assessment of this clientele (such as urea, eGFR, creatinine, calcium, phosphorus, PTH, urine tests, and other tests), usually ordered in this context.
  3. 3. To discuss the costs, benefits, usefulness and impact of repetitive usage of these tests for the management and for the clinical care of this clientele.
  4. 4. To debate the benefits of our current management of CKD patients, and explore other models of clinical care.
  5. 5. To integrate new management approaches for our CKD clientele in 2023 in this context.

Download files

9:20 - 10:30
“HYPERTENSION AND CHRONIC RENAL DISEASE; A DANGEROUS CONNECTION”

Dr. Rajiv Agarwal

“HYPERTENSION AND CHRONIC RENAL DISEASE; A DANGEROUS CONNECTION”

Speaker

Dr. Rajiv Agarwal, MBBS, MD, MS, FASN
Professor of Medicine, Indiana University
Staff Physician VA Medical Center
Indianapolis, IN, USA

TARGETED CANMEDS SKILLS:

  • Medical Expert
  • Health Advocate
  • Scholar

LEARNING OBJECTIVES:

  1. 1. To briefly review the prevalence of hypertension among chronic kidney disease stage 3 to 5.
  2. 2. To explore the mechanisms explaining the genesis of hypertension in chronic kidney disease.
  3. 3. To discuss the connection between hypertension and the occurrence of chronic kidney disease and between chronic kidney disease and the genesis of hypertension.
  4. 4. To debate the rationale of blood pressure targets to reach in the presence of CKD among different international societies (AHA, KDIGO, NICE, Canadian Society of Hypertension) and to explain the difference between these guidelines.
  5. 5. To propose, based on conclusions of trials, an “unified” definition of hypertension in the presence of CKD and the target blood pressure to reach.

Download files

10:30 - 11:05 - HEALTH BREAK Corporate zone
11:05 - 11:35
“INSOMNIA, CRAMPS, RESTLESS LEGS: THE TERRIBLE THREES”
“INSOMNIA AND RESTLESS LEGS: DIABOLICAL DUO” Part I

(Lecture in French)

Dr. Annie Lajoie

“INSOMNIA AND RESTLESS LEGS: DIABOLICAL DUO”

Speaker

Dr. Annie Lajoie, MD

Pneumologist
Associate Professor
Institut Universitaire de Pneumologie et de Cardiologie de Québec
Québec, QC
Canada

TARGETED CANMEDS SKILLS:

  • Medical Expert
  • Health Advocate
  • Scholar

LEARNING OBJECTIVES:

  1. 1. To discuss the prevalence of insomnia and restless leg syndrome, among CKD patients stage to 3 to 5D.
  2. 2. To explore the mechanisms explaining the occurrence of these symptoms.
  3. 3. To propose diagnostic criteria for these problems and to propose a day-to-day approach for its management.
  4. 4. To conceive a therapeutic plan for patients CKD stage 3 to 5D suffering from these symptoms.

Download files

11:35 - 12:05
“INSOMNIA, CRAMPS, RESTLESS LEGS: THE TERRIBLE THREES”
“CRAMPS AMONG CKD PATIENTS; CAN WE FINALLY SOLVE THIS PROBLEM?” Part II

Dr. Jennifer (Jenny) E. Flythe

“CRAMPS AMONG CKD PATIENTS; CAN WE FINALLY SOLVE THIS PROBLEM?” Part II

Speaker

Dr. Jennifer (Jenny) E. Flythe, MD, MPH

Associate Professor of Medicine
Vice Chief, Nephrology and Hypertension
Medical Director, Acute Dialysis Unit, UNC Hospital
Chapel Hill, NC, USA

TARGETED CANMEDS SKILLS:

  • Medical Expert
  • Health Advocate
  • Scholar

LEARNING OBJECTIVES:

  1. 1. To discuss the prevalence of cramps among CKD patients stage 3 to 5D
  2. 2. To explore the mechanisms explaining the occurrence of this symptom
  3. 3. To propose diagnostic criteria for this problem, and to propose a day-to-day approach for its management
  4. 4. To conceive a therapeutic plan for CKD patients, stage 3 to 5D suffering from this problem

Download files

12:05 - 12:20
COMBINED QUESTION PERIOD
12:20 - 12:30
CLOSING WORDS

Dr. Daniel Garceau

12:30 - 13:45
BUFFET LUNCH

Note: This program receives unrestricted educational grants from pharmaceutical companies Amgen Canada, Otsuka Canada and GSK Canada without any regards to the choice of speakers, topics, choice of members of scientific committee. We also offer our thanks to these pharmaceutical companies as exhibitors: Amgen Canada, Otsuka Canada, GSK Canada.